A detailed history of Sg Americas Securities, LLC transactions in Amgen Inc stock. As of the latest transaction made, Sg Americas Securities, LLC holds 55,359 shares of AMGN stock, worth $15.7 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
55,359
Previous 174,443 68.27%
Holding current value
$15.7 Million
Previous $54.5 Million 67.27%
% of portfolio
0.06%
Previous 0.32%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 03, 2024

SELL
$309.38 - $337.38 $36.8 Million - $40.2 Million
-119,084 Reduced 68.27%
55,359 $17.8 Million
Q2 2024

Jul 12, 2024

BUY
$262.75 - $319.31 $37.2 Million - $45.2 Million
141,634 Added 431.69%
174,443 $54.5 Million
Q1 2024

May 06, 2024

SELL
$268.87 - $324.56 $88.8 Million - $107 Million
-330,195 Reduced 90.96%
32,809 $9.33 Million
Q4 2023

Jan 12, 2024

BUY
$255.7 - $288.46 $82 Million - $92.5 Million
320,555 Added 755.15%
363,004 $105 Million
Q3 2023

Oct 13, 2023

SELL
$218.65 - $271.46 $440,142 - $546,448
-2,013 Reduced 4.53%
42,449 $11.4 Million
Q2 2023

Jul 10, 2023

BUY
$214.27 - $253.37 $6.1 Million - $7.21 Million
28,470 Added 178.03%
44,462 $9.87 Million
Q1 2023

Apr 28, 2023

SELL
$225.79 - $275.2 $6.59 Million - $8.03 Million
-29,184 Reduced 64.6%
15,992 $3.87 Million
Q4 2022

Feb 02, 2023

SELL
$229.03 - $291.01 $5.43 Million - $6.9 Million
-23,723 Reduced 34.43%
45,176 $11.9 Million
Q3 2022

Oct 31, 2022

SELL
$224.46 - $253.15 $2.38 Million - $2.68 Million
-10,583 Reduced 13.31%
68,899 $15.5 Million
Q2 2022

Jul 29, 2022

BUY
$230.71 - $256.74 $2.76 Million - $3.07 Million
11,950 Added 17.7%
79,482 $19.3 Million
Q1 2022

Apr 29, 2022

BUY
$219.27 - $242.57 $499,058 - $552,089
2,276 Added 3.49%
67,532 $16.3 Million
Q4 2021

Feb 07, 2022

BUY
$198.88 - $227.6 $4.76 Million - $5.45 Million
23,954 Added 58.0%
65,256 $14.7 Million
Q3 2021

Nov 01, 2021

SELL
$212.27 - $248.7 $73 Million - $85.5 Million
-343,697 Reduced 89.27%
41,302 $8.78 Million
Q2 2021

Aug 12, 2021

BUY
$233.58 - $259.14 $75.2 Million - $83.4 Million
321,824 Added 509.42%
384,999 $93.8 Million
Q1 2021

May 13, 2021

BUY
$221.91 - $258.6 $6.56 Million - $7.64 Million
29,560 Added 87.94%
63,175 $15.7 Million
Q4 2020

Feb 04, 2021

SELL
$216.38 - $257.67 $24.2 Million - $28.8 Million
-111,886 Reduced 76.9%
33,615 $7.73 Million
Q3 2020

Nov 09, 2020

BUY
$234.65 - $260.95 $22.1 Million - $24.6 Million
94,087 Added 183.0%
145,501 $37 Million
Q2 2020

Jul 20, 2020

BUY
$197.81 - $242.74 $3.09 Million - $3.79 Million
15,618 Added 43.63%
51,414 $12.1 Million
Q1 2020

Apr 30, 2020

SELL
$182.24 - $241.7 $1.2 Million - $1.6 Million
-6,601 Reduced 15.57%
35,796 $7.26 Million
Q4 2019

Jan 28, 2020

SELL
$189.21 - $243.2 $2.2 Million - $2.83 Million
-11,645 Reduced 21.55%
42,397 $10.2 Million
Q3 2019

Nov 04, 2019

SELL
$174.11 - $208.62 $10.9 Million - $13 Million
-62,380 Reduced 53.58%
54,042 $10.5 Million
Q2 2019

Jul 29, 2019

BUY
$166.7 - $195.41 $11 Million - $12.9 Million
66,170 Added 131.68%
116,422 $21.5 Million
Q1 2019

Apr 29, 2019

SELL
$180.87 - $203.88 $52.2 Million - $58.9 Million
-288,877 Reduced 85.18%
50,252 $9.55 Million
Q4 2018

Feb 01, 2019

BUY
$178.4 - $208.25 $32.7 Million - $38.2 Million
183,249 Added 117.56%
339,129 $66 Million
Q3 2018

Nov 06, 2018

SELL
$185.29 - $208.89 $16.8 Million - $18.9 Million
-90,428 Reduced 36.71%
155,880 $32.3 Million
Q2 2018

Aug 07, 2018

SELL
$166.05 - $186.51 $13.8 Million - $15.5 Million
-83,206 Reduced 25.25%
246,308 $45.5 Million
Q1 2018

May 03, 2018

BUY
$169.43 - $198.0 $45.7 Million - $53.4 Million
269,861 Added 452.38%
329,514 $56.2 Million
Q4 2017

Jan 24, 2018

BUY
$168.79 - $188.59 $1.73 Million - $1.93 Million
10,226 Added 20.69%
59,653 $10.4 Million
Q3 2017

Nov 07, 2017

BUY
$167.29 - $191.0 $8.27 Million - $9.44 Million
49,427
49,427 $9.22 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $152B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Sg Americas Securities, LLC Portfolio

Follow Sg Americas Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.